OBI Pharma Valuation
| 4174 Stock | TWD 60.80 1.00 1.62% |
At this time, the entity appears to be overvalued. OBI Pharma holds a recent Real Value of NT$55.19 per share. The prevailing price of the entity is NT$60.8. Our model determines the value of OBI Pharma from evaluating the entity fundamentals such as return on asset of -0.22, and Shares Owned By Insiders of 36.77 % as well as inspecting its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that OBI Pharma's price fluctuation is very steady at this time. Calculation of the real value of OBI Pharma is based on 3 months time horizon. Increasing OBI Pharma's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the OBI stock is determined by what a typical buyer is willing to pay for full or partial control of OBI Pharma. Since OBI Pharma is currently traded on the exchange, buyers and sellers on that exchange determine the market value of OBI Stock. However, OBI Pharma's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 60.8 | Real 55.19 | Hype 60.8 | Naive 61.81 |
The intrinsic value of OBI Pharma's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence OBI Pharma's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of OBI Pharma helps investors to forecast how OBI stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of OBI Pharma more accurately as focusing exclusively on OBI Pharma's fundamentals will not take into account other important factors: OBI Pharma Total Value Analysis
OBI Pharma is presently anticipated to have takeover price of 12.29 B with market capitalization of 17.7 B, debt of 28 M, and cash on hands of 3.57 B. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the OBI Pharma fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
12.29 B | 17.7 B | 28 M | 3.57 B |
OBI Pharma Investor Information
About 37.0% of the company shares are owned by insiders or employees . The book value of OBI Pharma was presently reported as 22.55. The company recorded a loss per share of 8.05. OBI Pharma had not issued any dividends in recent years. Based on the key measurements obtained from OBI Pharma's financial statements, OBI Pharma is not in a good financial situation at the moment. It has a very high risk of going through financial straits in January.OBI Pharma Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. OBI Pharma has an asset utilization ratio of 0.42 percent. This indicates that the Company is making NT$0.004184 for each dollar of assets. An increasing asset utilization means that OBI Pharma is more efficient with each dollar of assets it utilizes for everyday operations.OBI Pharma Ownership Allocation
OBI Pharma owns a total of 228.95 Million outstanding shares. OBI Pharma has substantial amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company maintains, if the real value of the entity is less than the current market value, you may not be able to make money on it.OBI Pharma Profitability Analysis
The company reported the revenue of 18.77 M. Net Loss for the year was (1.53 B) with loss before overhead, payroll, taxes, and interest of (25.59 M).About OBI Pharma Valuation
Our relative valuation model uses a comparative analysis of OBI Pharma. We calculate exposure to OBI Pharma's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of OBI Pharma's related companies.OBI Pharma, Inc., a bio-pharma company, develops and licenses novel therapeutic agents for unmet medical needs against cancer in Taiwan and internationally. The company was founded in 2002 and is based in Taipei, Taiwan. OBI PHARMA operates under Biotechnology classification in Taiwan and is traded on Taiwan OTC Exchange.
8 Steps to conduct OBI Pharma's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates OBI Pharma's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct OBI Pharma's valuation analysis, follow these 8 steps:- Gather financial information: Obtain OBI Pharma's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine OBI Pharma's revenue streams: Identify OBI Pharma's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research OBI Pharma's industry and market trends, including the size of the market, growth rate, and competition.
- Establish OBI Pharma's growth potential: Evaluate OBI Pharma's management, business model, and growth potential.
- Determine OBI Pharma's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate OBI Pharma's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Additional Tools for OBI Stock Analysis
When running OBI Pharma's price analysis, check to measure OBI Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy OBI Pharma is operating at the current time. Most of OBI Pharma's value examination focuses on studying past and present price action to predict the probability of OBI Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move OBI Pharma's price. Additionally, you may evaluate how the addition of OBI Pharma to your portfolios can decrease your overall portfolio volatility.